Mounjaro

Tirzepatide (marketed as Mounjaro for type 2 diabetes and Zepbound for weight loss) is a once-weekly, self-administered subcutaneous injection that acts as a GIP and GLP-1 receptor agonist.

It helps manage blood sugar and promotes significant weight loss.

Key Details About Tirzepatide: Uses: Used for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in conjunction with diet and exercise.

 Administration: It is injected once a week under the skin, typically in the abdomen, thigh, or upper arm. Mechanism: It works by mimicking the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormones to lower blood sugar and reduce appetite.

 Storage: The injection pen should be stored in the refrigerator